OPEN CLINICAL STUDY (San Diego): Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation

The goal of this study is to test whether a single low-dose of IV ketamine given in the emergency department to adolescents with treatment-resistant depression and suicidal ideation can reduce depression symptoms and suicidal thoughts compared to placebo. Participants will complete depression scales at baseline, and 1 hour, 3 hours, 1 day, 3 days, and 7 days after receiving the treatment.

MORE INFO: ClinicalTrials.gov